The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetesLana Bridi, Veeral Ajmera, Ricki Bettencourt et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 21
Su1521 PNPLA3 RISK VARIANT DISPROPORTIONATELY AMPLIFIES THE RISK OF ADVANCED FIBROSIS IN WOMEN IN A DIVERSE, PROSPECTIVE COHORT WITH TYPE 2 DIABETESVeeral Ajmera, Rohit Loomba, Saaket Agrawal et al.|Gastroenterology|2024Cited by 0